Vanguard Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.87M Buy
50,995
+6,211
+14% +$280K ﹤0.01% 1363
2026
Q2
$1.25M Hold
44,784
– – ﹤0.01% 1781
2026
Q1
$1.28M Buy
+44,784
New +$1.53M ﹤0.01% 1679

Other funds holding ATRC

Vanguard Asset Management's ATRC Position: Q3 2026 in Review

Vanguard Asset Management increased its AtriCure (ATRC) stake by 14% in Q3 2026, buying an estimated $280K and bringing the position to 50,995 shares worth $2.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1363.

Vanguard Asset Management first reported a position in ATRC in Q1 2026 and has held it in 3 quarters since. 283 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • Vanguard Asset Management held 50,995 shares of AtriCure worth $2.87M as of Q3 2026.
  • Vanguard Asset Management bought 6,211 AtriCure shares in Q3 2026, an estimated $280K.
  • AtriCure made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1363 holding.
  • Vanguard Asset Management first reported a position in AtriCure in Q1 2026 and has held it in 3 quarters since.
  • 283 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.